STATE OF INNOVATION SPEAKER SERIES
THE STATE OF INNOVATION SPEAKER SERIES BRINGS LEADING RESEARCHERS AND INDUSTRY EXPERTS
TO ENGAGE WITH THE CAMPUS COMMUNITY ON CUTTING EDGE SCIENCE TOPICS.
2019-2020: Innovation in Engineering & Materials Science
Kenneth Gall, PhD
Professor in the Department of Mechanical Engineering and Materials Science; Associate Dean for Entrepreneurship in the Pratt School of Engineering, Duke University
Dr. Gall will be joining us on December 11th and 12th.
Seminar details coming soon.
2018-2019: Regenerative Medicine
Shenda Baker, PhD
President & COO, Synedgen; Chief Science Officer, Synspira
April 23, 2019, Demo Day keynote: ”The Journey from Academia to Industry: A tale of therapeutic glycopolymers – bench to bedside and lessons learned”
Anthony Atala, MD
Director of the Wake Forest Institute for Regenerative Medicine
February 20, 2019: “Translational Tissue & Organ Regeneration: Advances and Future Frontiers”
Presented in collaboration with the C. Wayne McIlwraith Translational Medicine Institute
Debra Mathews, PhD, MA
Assistant Director for Science Programs, Johns Hopkins Berman Institute of Bioethics;
January 31, 2019: “Ethics and Technological Convergence: Regenerative Medicine, Whole Genome Sequencing, and CRISPR”
Zoobiquity Colorado: Connecting Human and Animal Health through Regenerative Medicine
October 5 & 6, 2018: Zoobiquity Colorado: Connecting Human and Animal Health through Regenerative Medicine
College of Veterinary Medicine & Biomedical Sciences at Colorado State University,
University of Colorado School of Medicine
Highlighted: Regenerative Medicine, Aging, Limb Preservation, Childhood Cancers, Auto-Immune Disorders
Provided group transportation and free student registrations in collaboration with the Graduate School.
Stephen Badylak, DVM, PhD, MD
Professor, Department of Surgery; Deputy Director, McGowan Institute for Regenerative Medicine
April 13, 2018, Demo Day keynote: “Clinical Translation of Regenerative Medicine: Combining Basic Science with Patient Care”
Vic Myer, PhD
Chief Technology Officer at Editas Medicine
February 21, 2018: “Perspectives from Industry: Harnessing the Power and Potential of CRISPR to Transform Medicine”
Rodolphe Barrangou, PhD, MBA
Todd R. Klaenhammer Distinguished Professor, NC State University; Editor in Chief at The CRISPR Journal
November 7, 2017: “The CRISPR craze: exploiting genome editing machines in academia and industry”
Intellectual Property Attorney for Polsinelli, PC
October 18, 2017: “Game of Unknowns: The CRISPR Patent Landscape”
Dan Voytas, PhD
Professor of Genetics, Cell Biology, & Development, University of Minnesota; Chief Science Officer, Calyxt
July 10, 2017: “Genome Editing in Rice: Development and Application”
Presented in collaboration with the Jan Leach Laboratory at Colorado State University.